Welcome Letter from
MIXiii-Biomed 2019

The Full Spectrum of Healthcare: From Prevention to Rehabilitation and Everything in Between

Dear Friends and Colleagues,

It is our honor and pleasure to invite you to participate in the 18th MIXiii-BIOMED Conference and Exhibition, to be held May 14-16, 2019 in Tel Aviv, Israel.


Robert C. King, PhD
Partner at Goldman Sachs International and Global Vice Chairman, Investment Banking Division

Amy W. Schulman
Managing Partner, LS Polaris Innovation Fund and Polaris Partners

Todd Brinton, MD
Corporate Vice President, Advanced Technology and Chief Scientific Officer, Edwards Lifesciences

Tom Sudow
Director, Business Development, Cleveland Clinic Innovations

Mark D. Stovsky, MD, MBA, FACS
Senior Director, Emerging Business, Cleveland Clinic Ventures

Jeroen Tas
Chief Innovation & Strategy Officer, Philips

Aharon Aharon
CEO, Israel Innovation Authority

Francois Maisonrouge
Senior Managing Director, Evercore Partners

Fiona de Hemptinne
Venture Partner, UCB Ventures

Miriam Frieden, PhD, MBA
VP of Search and Evaluation, Novo Nordisk

Tina Xu
Vice President of Information Technology and Head of Business Innovation, AstraZeneca, China

Laurent Choppe, DVM
Managing Partner, Cukierman & Co. Life Sciences

Zafrira Avnur, PhD
CSO & Partner, VP Quark Venture Inc.

Max Zeiberg
Corporate Development, Gilead Sciences

Aya Jakobovits, PhD
Founder, Director, Adicet Bio

Erez Chimovits
Senior Managing Director, OrbiMed Advisors

Anat Naschitz
Managing Director, OrbiMed Advisors

Irit Yaniv, MD
General Partner, Accelmed

Ron Ginor, MD
Venture Partner, OrbiMed Advisors

Naomi Gefen
Deputy Director General, ALYN Hospital

Prof. Yael Hanein, PhD
School of Electrical Engineering, Tel Aviv University

Yaron Daniely, PhD
CEO, Yissum

Yael Weiss, MD, PhD
Vice President Business Development, Ultragenyx

Stephen Squinto, PhD
Interim CEO, Passage Bio

Prof. David Sidransky, MD
Johns Hopkins School of Medicine; Co-Founder and General Partner, Israel Biotech Fund

Prof. Varda Shalev, MD, MPA
Managing Director, Morris Kahn & Maccabi Research and Innovation Institute at Maccabi Health Care Services

Yair Schindel, MD
Co-Founder & Managing Partner, aMoon Fund

Allen Kamer
Managing Partner, OurCrowd Qure

Prof. Simon Benita, PhD
Head of Nano Delivery Systems, Hebrew University of Jerusalem

Ayelet Torem, Adv.
Partner, Hi-Tech & Venture Capital and Head of Global Markets, Amit, Pollak, Matalon & Co

Dorman Followwill
Senior Partner, Frost & Sullivan

Prof. Nadav Ahituv, PhD
Department of Bioengineering and Therapeutic Science, University of California San Francisco

Rachel Haurwitz, PhD
Co-founder, President and CEO, Caribou Biosciences

Ulrich Brinkmann, PhD
Scientific Director, Roche Pharma Research & Early Development, Roche Diagnostics GmbH

Michal J. Besser, PhD
Head of Laboratory, Ella Lemelbaum Institute for Immuno Oncology & Director, Wohl GMP Facility, Sheba Medical Center; Assistant Professor, Dept. of Microbiology and Immunology, School of Medicine, Tel Aviv University

Adi Barzel, PhD
Senior Lecturer, Department of Biochemistry at Tel Aviv University; Co-Founder of LogicBio Therapeutics, Inc.; President of the Israeli Society of Gene and Cell Therapy

Bruce R. Rosengard, MD
VP, Global External Innovation, Johnson and Johnson Medical Devices

John J. Smith, MD
Partner, Hogan Lovells

Prof. Elizabeth Croydon
Senior Clinical Director, Oncology – EU Clinical Development, Merck Sharp & Dohme

Trevor Martin, PhD 
CEO and Co-Founder, Mammoth Biosciences

Elliot Menschik, MD, PhD
Global Head, Healthcare + Life Science Startups, Amazon Web Services

Kelly Krajnik
Senior Manager, Devices, Diagnostics, Mayo Clinic Ventures

Prof. Eitan Friedman, MD, PhD
Director & Founder of The Suzanne Levy-Gertner Oncogenetics Unit, Sheba Medical Center

Michal Rosen-Zvi
Director, Healthcare Informatics, IBM Research

Wade Ackerman
FDA Regulatory group, Co-Lead of Digital Health Initiative, Covington & Burling LLP

Gary Gordon, MD, PhD
Former Vice President, Global Oncology Development, AbbVie, Inc

Prof. Joel V. Brill, MD, FACP
Chief Medical Officer, Predictive Health. LLC

Prof. Yaakov Nahmais, PhD
Director, Grass Center for Bioengineering, The Hebrew University of Jerusalem

Prof. David Mirelman, PhD
Weizmann Institute of Science

Prof. Daniel Offen, PhD
Tel Aviv University

Prof. Gal Markel, MD, PhD
Tel Aviv University

Eran Stark, MD, PhD
Sackler Faculty of Medicine, Tel Aviv University

Carl L. Gordon, PhD
Managing Partner, OrbiMed Advisors

Nicholas Pachuda
WW Vice President, Orthopedic Innovation, J&J Medical Devices

Eric Tansky
Managing Director, Oppenheimer & Co. Inc.

Prof. Hinanit Koltai, PhD
Agricultural Research Organization (ARO), Volcani Center

Prof. Raphael Mechoulam, PhD
Hebrew University of Jerusalem

Prof. Itamar Raz, MD
Head, The Israeli National Diabetes Council

Medy Wiener
Chief Medical Officer, BOL Pharma

Hadas Bitran
Head of Healthcare Israel, Microsoft

Ziv Ofek
Founder and CEO, MDClone

Tamara Mansfeld
Global Innovation Lead, Pfizer

Leif E. Pedersen
CEO, Dassault Systemes BIOVIA

Don Mathis
General Manager, Growth Comcast NBCUniversal

Prof. Angel Porgador, PhD
Ben Gurion University

Prof. Ofer Mandelboim, PhD
Hebrew University of Jerusalem

Maurit Beeri, MD
Director General, ALYN Hospital

Sagit Arbel-Alon, MD
Deputy Director, Reuth Medical & Rehabilitation Hospital

Yoav Medan, PhD

Yaron Galitzky
General Manager, Devices and Accessories, Microsoft

Ziv Shilon
Co-founder, COO, 6Degrees

Itamar Offer, MD, MPA
CEO, Sabar Health

Aviv Zeevi, PhD
VP, Technology Infrastructure, Israel Innovation Authority

Prof. Tal Dvir, PhD
Tel Aviv University

Regine Shevach
Managing Director, Inter-Lab, an affiliate of Merck KGaA

Shai Policker
CEO, Medex Xelerator LP

Avinatan Hassidim
Head of TLV Research, Google

Uma Makhija
Business Development Lead, Digital Health, Otsuka Pharmaceuticals

Ronald G. Crystal, MD
Founder, LEXEO Therapeutics and Chair, Department of Genetic Medicine, Weill Cornell Medical College

On the agenda

14 May 2019

Gene Editing and Gene Therapy: The Next Frontier in Human Health
Transforming Medicine: Artificial Intelligence and Digital Health
Disruptive and Advanced Medical Devices

15 May 2019

Prevention and Rehabilitation: Should the Underdog Begin Barking?
Tango of the Two: Academia and Industry
New Modalities of Cell Therapies: Revolutionizing the Way We Treat Diseases

16 May 2019

Transformative Cancer Therapies
Personalized Medicine and Digital Health: Lessons Learned and Challenges Ahead
Cannabis’ Therapeutic Promise: Hope or Hype?












Be Informed, Stay Informed

Follow us on:

Join our group in LinkedIn:



Read all news about the event and the field in our blog: